Preferred Stock |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Equity [Abstract] | |
| Preferred Stock | Preferred Stock
Rights and Preferences of the Series A, B and C Preferred Stock - The Series A, B and C Preferred Stock of the Company, with respect to the payment of dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company, ranks senior to all capital stock of the Company, unless the Required Holders (as defined in the applicable Certificate of Designations) consent to the creation of other capital stock of the Company that is senior or equal in rank to the specific series of Preferred Stock. For the avoidance of doubt, the Series A, B and C Preferred Stock ranks in parity with each other.
The holders of Series B and C Preferred Stock will be entitled to a 10% per annum dividends and holders of Series A Preferred Stock will be entitled to 5% per annum dividends. The dividends are payable to each record holder of the Preferred Stock in shares of Common Stock so long as there has been no Equity Conditions Failure (as defined in the applicable Certificate of Designations), and the Company may, at its option, under certain circumstances, capitalize the dividend by increasing the stated value of each Preferred Shares or elect a combination of the capitalized dividend and a payment in dividend shares. During the three months ended September 30, 2026, the Company recognized preferred stock dividends totaling $300,297 consisting of $73,133, $53,982 and $173,182 attributable to Series A, B and C Preferred Stock, respectively. During the nine months ended September 30, 2026, the Company recognized preferred stock dividends totaling $705,845 consisting of $219,757, $177,256 and $308,832 attributable to Series A, B and C Preferred Stock, respectively.
Management has elected to capitalize dividends on each dividend date, which is the first Trading Day of the quarter after to which the dividend relates. During the three months ended September 30, 2026, dividends relating to the Series A, B and C Preferred Stock of $74,958, $54,006 and $65,782, respectively, were capitalized. During the nine months ended September 30, 2026, dividends relating to the Series A, B and C Preferred Stock of $219,772, $194,999 and $153,159, respectively, were capitalized. The stated value of the Series A and B Preferred Stock increased to $1,077 and $1,093, respectively. The stated value of the Series C Preferred Stock was $1,046 for stock held by ATW I and $1,001 for stock held by a non-related party investor. At September 30, 2026, dividends payable of $71,942, $53,656 and $172,425 relating to Series A, B and C Preferred Stock, respectively, were reported under other liabilities in the Condensed Consolidated Balance Sheets. At December 31, 2025, dividends payable of $71,958, $71,399 and $16,753 relating to Series A, B and C Preferred Stock, respectively, were reported under other liabilities in the Condensed Consolidated Balance Sheets.
Series A Convertible Preferred Stock - A total of 5,342 shares of Series A Convertible Preferred Stock were outstanding as of September 30, 2026, held by related party MIF.
On August 12, 2026, the Company entered into a Fourth Amendment to the 2023 Term Loan Agreement with each lender, pursuant to which the conversion price was reduced to $10.80 for the period ending on August 13, 2026. On September 30, 2026, the Company entered into a Sixth Amendment to the 2023 Term Loan Agreement with each lender, pursuant to which the conversion price was reduced to $1.488 for the period ending October 2, 2026. Both Amendments constitute a deemed issuance under the Certificate of Designations governing the Series A Convertible Preferred Stock (the "Series A Certificate") and the conversion price of the Series A Convertible Preferred Stock was reduced from $28.51 to $10.80 on August 12, 2026 and from $10.80 to $1.49 on September 30, 2026. The expiration of the temporary reduction window does not reverse the conversion price reduction of the Series A Convertible Preferred Stock. The resulting value transfers of $370,094 at August 12, 2026 and $3,323,205 at September 30, 2026 were recorded as reclassifications within equity (charged to Accumulated Deficit and credit to APIC) and treated as a deemed dividend to preferred shareholders for EPS purposes. There was no impact on total stockholders' equity or the consolidated statement of operations.
On September 30, 2026, the Company received an executed waiver from a holder of its Series A Convertible Preferred Stock. Section 5(a)(xv) of the certificate of designations for the Series A Convertible Preferred Stock provides that a Triggering Event (as defined in the Series A Certificate) occurs if any shares of the Series A Convertible Preferred Stock remain outstanding on or after September 30, 2026 (the “Series A Specified Event”). The Holder waived the Series A Specified Event for the period beginning September 30, 2026 and continuing through and including January 31, 2027. Solely to the extent attributable to the Series A Specified Event during the period covered by the Waiver, the Holder waived the increase in the dividend rate to the default rate of 18% per annum (or the maximum lawful rate, if lower), related incremental dividends, and the right to a Triggering Event Conversion (as defined in the Series A Certificate), including the 125% multiplier applied to the Conversion Amount (as defined in the Series A Certificate) (a 25% premium) and any related surviving alternate conversion period. The Waiver also relieves the Company of the related Triggering
Event notice requirement and provides that the Series A Specified Event is disregarded for purposes of the applicable Equity Conditions (as defined in the Series A Certificate) and the other consequences specified in the Waiver.
During the nine months ended September 30, 2026, SLS converted 204 shares of Series A Convertible Preferred Stock into 30,641 shares of Common Stock, respectively. During the nine months ended September 30, 2025, ATW I and SLS converted 19,038 and 2,300 shares of Series A Convertible Preferred Stock into 58,118 and 6,474 shares of Common Stock, respectively.
Series B Convertible Preferred Stock - A total of 1,963 shares of Series B Convertible Preferred Stock were outstanding at September 30, 2026, held by related party ATW II.
On August 12, 2026, the Company entered into a Fourth Amendment to the 2023 Term Loan Agreement with each lender, pursuant to which the conversion price was reduced to $10.80 for the period ending on August 13, 2026. On September 30, 2026, the Company entered into a Sixth Amendment to the 2023 Term Loan Agreement with each lender, pursuant to which the conversion price was reduced to $1.488 for the period ending October 2, 2026. Both Amendments constitute a deemed issuance under the Certificate of Designations governing the Series B Convertible Preferred Stock (the "Series B Certificate") and the conversion price of the Series B Convertible Preferred Stock was reduced from $28.51 to $10.80 on August 12, 2026 and from $10.80 to $1.49 on September 30, 2026. The expiration of the temporary reduction window does not reverse the conversion price reduction of the Series B Convertible Preferred Stock. The resulting value transfers of $146,950 at August 12, 2026 and $1,278,934 at September 30, 2026 were recorded as reclassifications within equity (charged to Accumulated Deficit and credit to APIC) and treated as a deemed dividend to preferred shareholders for EPS purposes. There was no impact on total stockholders' equity or the consolidated statement of operations.
On September 30, 2026, the Company received an executed waiver from a holder of its Series B Convertible Preferred Stock. Section 5(a)(xv) of the certificate of designations for the Series B Convertible Preferred Stock provides that a Triggering Event occurs if any shares of the Series B Convertible Preferred Stock remain outstanding on or after September 30, 2026 (the “Series B Specified Event”). The Holder waived the Series B Specified Event for the period beginning September 30, 2026 and continuing through and including March 31, 2027. Solely to the extent attributable to the Series B Specified Event during the period covered by the Waiver, the Holder waived the increase in the dividend rate to the default rate of 18% per annum (or the maximum lawful rate, if lower), related incremental dividends, and the right to a Triggering Event Conversion (as defined in the Series B Certificate), including the 125% multiplier applied to the Conversion Amount (as defined in the Series B Certificate) (a 25% premium) and any related surviving alternate conversion period. The Waiver also relieves the Company of the related Triggering Event notice requirement and provides that the Series B Specified Event is disregarded for purposes of the applicable Equity Conditions (as defined in the Series B Certificate) and the other consequences specified in the Waiver.
During the three and nine months ended September 30, 2026, 50 and 850 shares of Series B Convertible Preferred Stock were converted into 14,047 and 49,750 shares of Common Stock, respectively.
Series C Convertible Preferred Stock - A total of 6,824 shares of Series C Convertible Preferred Stock were outstanding at September 30, 2026, of which 2,024 were held by related party ATW II.
On June 26, 2026, the Company entered into an Exchange Agreement pursuant to which a lender exchanged a total of $4,000,000 2023 Term Loan notes, with principal and interest amounts of $2,146,701 and $1,853,299, respectively, for 4,800 shares of Series C Convertible Preferred Stock with a stated value of $4,800,000. The fair value of the Series C Preferred Stock was $8,320,000 and a loss on extinguishment of debt of $4,320,000 was reported in the condensed consolidated statements of operations for the nine months ended September 30, 2026.
On August 12, 2026, the Company entered into a Fourth Amendment to the 2023 Term Loan Agreement with each lender, pursuant to which the conversion price was reduced to $10.80 for the period ending on August 13, 2026. On September 30, 2026, the Company entered into a Sixth Amendment to the 2023 Term Loan Agreement with each lender, pursuant to which the conversion price was reduced to $1.488 for the period ending October 2, 2026. Both Amendments constitute a deemed issuance under the Certificate of Designations governing the Series C Convertible Preferred Stock (the "Series C Certificate") and the conversion price of the Series C Convertible Preferred Stock was reduced from $45.60 to $10.80 on August 12, 2026 and from $10.80 to $1.49 on September 30, 2026. The expiration of the temporary reduction window does not reverse the conversion price reduction of the Series C Convertible Preferred Stock. The resulting value transfers of
$475,343 at August 12, 2026 and $4,124,225 at September 30, 2026 were recorded as reclassifications within equity (charged to Accumulated Deficit and credit to APIC) and treated as a deemed dividend to preferred shareholders for EPS purposes. There was no impact on total stockholders' equity or the consolidated statement of operations.
On September 23 and 30, 2026, the Company received executed waivers from a holders of its Series C Convertible Preferred Stock. Section 5(a)(xv) of the certificate of designations for the Series C Convertible Preferred Stock provides that a Triggering Event occurs if any shares of the Series C Convertible Preferred Stock remain outstanding on or after September 30, 2026 (the “Series C Specified Event”). The Holders waived the Series C Specified Event for the period beginning September 30, 2026 and continuing through and including March 31, 2027 and December 31, 2027, respectively. Solely to the extent attributable to the Specified Event during the period covered by the Waivers, the Holders waived the increase in the dividend rate to the default rate of 18% per annum (or the maximum lawful rate, if lower), related incremental dividends, and the right to a Triggering Event Conversion (as defined in the Series C Certificate), including the 125% multiplier applied to the Conversion Amount (as defined in the Series C Certificate) (a 25% premium) and any related surviving alternate conversion period. The Waivers also relieve the Company of the related Triggering Event notice requirement and provides that the Serie C Specified Event is disregarded for purposes of the applicable Equity Conditions (as defined in the Series C Certificate) and the other consequences specified in the Waivers.
During the nine months ended September 30, 2026, November 2024 Debentures with a principal value of $2,000,000 and fair value of $2,729,994, were exchanged into 2,023 shares of Series C Convertible Preferred Stock. The fair value of the Series C Convertible Preferred Stock was $3,659,502 and a loss on extinguishment of debt of $929,508 was reported in the condensed consolidated statements of operations for the nine months ended September 30, 2026.
During the three and nine months ended September 30, 2026, 369 and 2,153 shares of Series C Convertible Preferred Stock were converted into 50,012 and 222,454 shares of Common Stock, respectively.
Series D Convertible Preferred Stock - On February 6, 2026, the Company entered into a Securities Purchase Agreement and a registration rights agreement with Master Investment Group ("Investor"), pursuant to which the Company agreed to issue and sell in a private offering to Investor, (1) certain shares of Series D Convertible Preferred Stock of the Company, $0.0001 par value (the “Series D Preferred Stock”) for an aggregate purchase price of up to $3,000,000 and may issue additional shares of Series D Preferred Stock valued at up to $47,000,000 and (2) certain common stock purchase warrants (the “Warrants”) to purchase up to a number of shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), equal to 30% of the aggregate purchase price (the “Preferred Offering”). The Preferred Offering also relates to the offering of the shares of the Common Stock issuable upon the conversion of or otherwise pursuant to the terms of the Series D Preferred Stock (“Conversion Shares”) and the shares of the Common Stock issuable upon the exercise of the Warrants.
Pursuant to the Purchase Agreement, the Company agreed to issue the Initial Preferred Shares for an aggregate purchase price of $3,000,000 in two closings, in each case following the demonstration that Investor has made expenditures agreed by, and on behalf of, the Company in an aggregate amount equal to the applicable milestone aggregate investment amount specified in the Purchase Agreement. At each such milestone closing, the Company will issue to Investor a number of shares of Series D Preferred Stock equal to the applicable milestone aggregate investment amount invested by Investor, at a price of $1,000 per share. The Company and Investor agree that the proceeds of the Preferred Offering will be deployed exclusively as UAE related working capital to fund and support, directly or indirectly, the establishment and operation of the Company’s business in the United Arab Emirates.
In addition, for a period of up to 3 years from the date of the Purchase Agreement (or such later date as mutually agreed to by the Company and Investor), by written notice from the Company to Investor and subject to other terms and conditions set forth in the Purchase Agreement, the Company may require the Investor to participate in one or more additional milestone closings and issue additional shares of Series D Preferred Stock to Investor up to an aggregate maximum purchase price of $47,000,000 in one or more tranches, and additional Warrants exercisable for an amount of shares of Common Stock with an aggregate initial value equal to 30% of the value of the Series D Preferred Stock to be issued at each such additional closings, subject to mutually agreed milestones, assignments, and definitive documentation, and in each case, consent of certain existing holders of securities of the Company.
The Purchase Agreement further provides for a two-year lock-up period, during which Investor shall not, without the prior written consent of the Company and certain existing holders of securities of the Company, sell, transfer, pledge or
otherwise dispose of any shares of Common Stock upon conversion of the Series D Preferred Stock, nor enter into any swap or other arrangement that transfers the economic consequence of ownership of such shares.
Pursuant to the Registration Rights Agreement, the Company agreed that in the event that the Company files a registration statement with the Securities and Exchange Commission, registering the offer and sale of any shares of its Common Shares under the Securities Act, the Investor shall have the option to require the Company to include registration under the Securities Act of 1933, as amended (the “Securities Act”), of the resale by Investor of shares of Common Stock issuable upon conversion of the Series D Preferred Stock and upon the exercise of the Warrants.
The Purchase Agreement and the Registration Rights Agreement contain customary representations, warranties, conditions and indemnification obligations of the parties.
On July 6, 2026, the Company designated 50,000 shares of the Company’s authorized and unissued preferred stock as Series D Preferred Stock and established the rights, preferences and privileges of the Series D Preferred Stock pursuant to the Certificate of Designations of Series D Preferred Stock, filed with the Secretary of State of the State of Delaware.
As of September 30, 2026 no shares of Series D Preferred Stock had been issued pursuant to the Purchase Agreement. During the three months ended September 30, 2026, the Company received advertising services valued at $79,950 in connection with the arrangement. As the contractual milestones required for the issuance of the Series D Preferred Stock had not been achieved as of September 30, 2026, the Company recognized the cost of these services and recorded a corresponding liability of $79,950 within accounts payable in the condensed consolidated balance sheets.
Warrants - The Warrants, when issued pursuant to the Purchase Agreement, are immediately exercisable upon issuance and will expire on the fifth anniversary of the original issuance date. The Warrants have an initial exercise price equal to $53.40, subject to certain adjustments as described in the Warrant.
A Warrant holder will not have the right to exercise any portion of the Warrants to the extent that, after giving effect to such conversion, the holder would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the number of shares of the Common Stock outstanding immediately after giving effect to such conversion.
Corrections to Certificates of Designations - On April 15, 2026, the Company filed with the Secretary of State of the State of Delaware, amendments to the Certificates of Designations of Rights and Preferences, respectively, of the Series A Convertible Preferred Stock, the Series B Convertible Preferred Stock, and the Series C Convertible Preferred Stock, to correct an error in each such instrument.
|